International Archives of Medicine · 2012 · 44 citations · 119 references
MedicineClinical SciencesVeterinary Clinical SciencesRheumatologyStem Cell BiologyStem Cell TransplantationAutoimmune DiseasesAutoimmune Rheumatic DiseasesInflammatory ArthritisMesenchymal Stem Cell TherapyMesenchymal Stromal Cell TherapyRheumatoid ArthritisAutologous Mesenchymal Stromal Cell TherapyAutologous Stem Cell TherapyDegenerative Joint Disease RepairPatient Outcomes MeasurementRheumatoid Arthritis TherapySerious Adverse EventsStem Cell-based Therapy
Advancements in rheumatoid arthritis (RA) treatment protocols and introduction of targeted biological therapies have markedly improved patient outcomes, despite this, up to 50% of patients still fail to achieve a significant clinical response. In veterinary medicine, stem cell therapy in the form of autologous stromal vascular fraction (SVF) is an accepted therapeutic modality for degenerative conditions with 80% improvement and no serious treatment associated adverse events reported. Clinical translation of SVF therapy relies on confirmation of veterinary findings in targeted patient populations. Here we describe the rationale and preclinical data supporting the use of autologous SVF in treatment of RA, as well as provide 1, 3, 6, and 13 month safety outcomes in 13 RA patients treated with this approach.
119
Multilineage Potential of Adult Human Mesenchymal Stem Cells
Mark F. Pittenger, Alastair M. Mackay, Stephen C. Beck et al. · Science · 1999 · 21.1K citations
Isolation of Putative Progenitor Endothelial Cells for Angiogenesis
Takayuki Asahara, Toyoaki Murohara, Alison Sullivan et al. · Science · 1997 · 8.7K citations
Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based Therapies
Patricia A. Zuk, Min Zhu, Hiroshi Mizuno et al. · Tissue Engineering · 2001 · 8K citations
Human Adipose Tissue Is a Source of Multipotent Stem Cells
Patricia A. Zuk, Min Zhu, Peter Ashjian et al. · Molecular Biology of the Cell · 2002 · 6.7K citations